Authors: SPRIET A CHAUMETRIFFAUD P ALLARD M BILLARDON M CATTELIN F CHILDS M DELACOURTE M DELALLEAU B DIGIAMBERARDINO L EMRE M GENTHON R GONI S JAFFARD R LACOMBLEZ L LEBERT F LEGER JM MAHIEUX F MICHEL B PARTIOT A PASQUIER F PAUL HPS PUECH A REIGNEAU O RENAULT S SCHLENCK A

Citation: A. Spriet et al., ESSENTIAL ELEMENTS OF QUALITY ASSURANCE O F CLINICAL-TRIALS IN-HOSPITAL SETTING, Therapie, 51(4), 1996, pp. 434-438

Authors: DUBOIS B STEHLE B LEHNER JP DEROUESNE C BOURIN M LAMOUR Y BLIN O JOURDAIN G ALPEROVITCH A ALLARD M BILLARDON M CATTELIN F CHILDS M DELACOURTE M DELALLEAU B DIGIAMBERARDINO L EMRE M GENTHON R GONI S JAFFARD R LACOMBLEZ L LEBERT F LEGER JM MAHIEUX F MICHEL B PARTIOT A PASQUIER F PAUL HPS PUECH A REIGNEAU O RENAULT S SCHLENCK A

Citation: B. Dubois et al., METHODOLOGY FOR DEVELOPING DRUGS IN ALZHE IMER-DISEASE, Therapie, 51(4), 1996, pp. 444-448